128 related articles for article (PubMed ID: 12938523)
21. Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy.
Cui F; Qu D; Sun R; Nan K
Med Oncol; 2019 Sep; 36(10):84. PubMed ID: 31493232
[TBL] [Abstract][Full Text] [Related]
22. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells.
Matsumoto S; Imaeda Y; Umemoto S; Kobayashi K; Suzuki H; Okamoto T
Br J Cancer; 2002 Jan; 86(2):161-7. PubMed ID: 11870500
[TBL] [Abstract][Full Text] [Related]
23. The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer.
Gharagozloo M; Kalantari H; Rezaei A; Maracy MR; Salehi M; Bahador A; Hassannejad N; Narimani M; Sanei MH; Bayat B; Ghazanfari H
Bratisl Lek Listy; 2015; 116(5):296-301. PubMed ID: 25924638
[TBL] [Abstract][Full Text] [Related]
24. Synergistic antitumor activity of interleukin-2 and cimetidine against syngeneic murine tumor.
Nakajima I; Chu TM
Cancer Immunol Immunother; 1991; 33(1):9-14. PubMed ID: 2021961
[TBL] [Abstract][Full Text] [Related]
25. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients.
Qiu L; Wang DR; Zhang XY; Gao S; Li XX; Sun GP; Lu XB
Transfus Apher Sci; 2016 Apr; 54(2):235-41. PubMed ID: 26780991
[TBL] [Abstract][Full Text] [Related]
26. Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial.
Haldar R; Ricon-Becker I; Radin A; Gutman M; Cole SW; Zmora O; Ben-Eliyahu S
Cancer; 2020 Sep; 126(17):3991-4001. PubMed ID: 32533792
[TBL] [Abstract][Full Text] [Related]
27. Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies.
Marshall ME; Riley LK; Rhoades J; Eichhorn T; Jennings CD; Cibull M; Thompson J
J Biol Response Mod; 1989 Feb; 8(1):62-9. PubMed ID: 2921610
[TBL] [Abstract][Full Text] [Related]
28. Association of Anger Expression-Out with NK Cell Counts in Colorectal Cancer Patients.
Kakoo-Brioso E; Costa L; Ouakinin S
Acta Med Port; 2018 Mar; 31(3):152-158. PubMed ID: 29790466
[TBL] [Abstract][Full Text] [Related]
29. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery.
Heiss MM; Fasol-Merten K; Allgayer H; Ströhlein MA; Tarabichi A; Wallner S; Eissner HI; Jauch KW; Schildberg FW
Vox Sang; 1997; 73(4):237-45. PubMed ID: 9407641
[TBL] [Abstract][Full Text] [Related]
30. [Effect of cimetidine with chemotherapy on stage IV colorectal cancer].
Yoshimatsu K; Ishibashi K; Hashimoto M; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Iwasaki K; Ogawa K
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1794-7. PubMed ID: 14619522
[TBL] [Abstract][Full Text] [Related]
31. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the antitumor activity of interleukin-12 in an experimental murine model of colorectal cancer induced by 1,2 dimethyl-hydrazine (DMH).
Coca S; Enrech S; Moreno García V; Sáez MA; Gutiérrez C; Colmenarejo A; Hernández JM; Pérez Piqueras J
Rev Esp Enferm Dig; 2005 Sep; 97(9):619-28. PubMed ID: 16266234
[TBL] [Abstract][Full Text] [Related]
33. Impaired local natural killer cell activity in human colorectal carcinomas.
Aparicio-Pagés NM; Verspaget HW; Peña SA; Lamers CB
Cancer Immunol Immunother; 1989; 28(4):301-4. PubMed ID: 2495180
[TBL] [Abstract][Full Text] [Related]
34. Adverse effects of intraportal chemotherapy on natural killer cell activity in colorectal cancer patients.
Rafique M; Adachi W; Koike S; Kajikawa S; Yazawa K; Sugenoya A; Amano J
J Surg Oncol; 1997 Apr; 64(4):324-30. PubMed ID: 9142191
[TBL] [Abstract][Full Text] [Related]
35. Preoperative Tim‑3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer.
Wang Y; Sun J; Gao W; Song B; Shao Q; Zhao L; Zhang Y; Wang Q; Zhang Y; Qu X
Mol Med Rep; 2017 Jun; 15(6):3810-3818. PubMed ID: 28440449
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cells over time in patients with colorectal cancer.
Orsi AJ; Tax AW; Nuamah I; Barsevick A; McCorkle R
Cancer Pract; 1996; 4(5):252-7. PubMed ID: 9004571
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Perioperative Cimetidine Administration on Time to Colorectal Cancer Recurrence.
Ali AH; Hale L; Yalamanchili B; Ahmed M; Ahmed M; Zhou R; Wright SE
Am J Ther; 2018; 25(4):e405-e411. PubMed ID: 29630589
[TBL] [Abstract][Full Text] [Related]
38. Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome.
Krijgsman D; Roelands J; Andersen MN; Wieringa CHLA; Tollenaar RAEM; Hendrickx W; Bedognetti D; Hokland M; Kuppen PJK
Mol Immunol; 2020 Dec; 128():205-218. PubMed ID: 33142138
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells.
Santos MF; Mannam VK; Craft BS; Puneky LV; Sheehan NT; Lewis RE; Cruse JM
Exp Mol Pathol; 2014 Jun; 96(3):367-74. PubMed ID: 24731923
[TBL] [Abstract][Full Text] [Related]
40. Recombinant leukocyte A interferon as single agent therapy or in combination with cimetidine in patients with advanced colo-rectal carcinoma. A phase II investigation.
Flodgren P; Hugander A; Sjögren HO
Acta Radiol Oncol; 1985; 24(1):25-34. PubMed ID: 2984899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
